This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Linenberger, M. L. Articles by Price, T. H. Search for Related Content PubMed PubMed Citation Articles by Linenberger, M. L. Articles by Price, T. H. Social Bookmarking                         What's this?

Use of Cellular and Plasma Apheresis in the Critically Ill Patient: Part 1: Technical and Physiological Considerations

Seattle Cancer Care Alliance, Seattle, WA; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA.

Thomas H. Price, MD

Puget Sound Blood Center, Seattle, WA; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA.

Apheresis is the process of separating the blood and removing or manipulating a cellular or plasma component for therapeutic benefit. An apheresis procedure, or series of procedures, may be indicated in the critical care setting as primary or adjunctive therapy for certain hematologic, neurologic, renal, and autoimmune/ rheumatologic disorders. Optimal management of severely ill patients undergoing apheresis requires a working knowledge of the technical, methodological, and therapeutic considerations. These considerations include instrument hardware and separation methods, vascular access requirements, hemodynamic and hemostatic effects of the procedures, exposure to anticoagulants and homologous blood products, physiological variables affecting blood/plasma processing efficiency, and therapeutic endpoints for specific indications. Part 1 of this review will discuss each of those technological considerations and the basic physiological principles that guide this form of therapy. Part 2 of this series will deal with the clinical indications and applications for specific disorders that are most likely to affect patients in the intensive care unit.

Key Words: apheresis • therapeutic plasma exchange • plateletpheresis • leukapheresis • red cell exchange

Journal of Intensive Care Medicine, Vol. 20, No. 1, 18-27 (2005)
DOI: 10.1177/0885066604271394


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?